World Cancer Day 2014 – Disease Review

REUTERS/Ivan Canabrava

World Cancer Day 2014 (4 February 2014)  is a chance to raise our collective voices in the name of improving general knowledge around cancer and dismissing misconceptions about the disease ( In celebration of this critical awareness day, Thomson Reuters is offering a series of free reports on a variety of different forms of cancer and treatments. Continue reading to review and download these insightful reports:

Spotlight On Chronic Myeloid Leukemia

With the advent of targeted therapy, chronic myeloid leukemia (CML) has undergone a major transformation from a terminal disease to an essentially manageable chronic condition. Despite significantly improved survival rates, there still remains room for improvement in efficacy, tolerability, and resistance potential.

Download report here >>

Spotlight On Melanoma

The melanoma therapy market is currently experiencing an innovation breakthrough. Prior to 2011, patients with advanced melanoma were faced with poor prognosis and very limited treatment options, and the mainstay drugs DTIc (dacarbazine) and Proleukin were associated with poor response rates and a litany of toxicity issues.

Download report here >>

Spotlight On Multiple Myeloma

Despite the therapeutic advances made over the last decade with the introduction of the immunomodulatory and proteasome inhibitor drug classes, multiple myeloma is still associated with a poor prognosis and has one of the lowest five-year survival rates in oncology. The disease remains incurable, and successfully maintaining remission is an uphill battle. Therapy is complicated by multiple settings and regimens, with a lack of long-term data from large-scale comparative trials to aid treatment choices.

Download report here >>

Spotlight On Non-Small-Cell Lung Cancer

Over the past decade, a multitude of targeted agents have been explored in the treatment of non-small-cell lung cancer (NSCLC) and there are now three classes of agents which have been implemented in clinical practice.

Download report here >>

Spotlight On Radiotherapeutics

The field of radiotherapeutics was, until recently, one where sales were considered lackluster. The difficulties inherent in making and administering drugs that are radioactive have often outweighed the clinical benefits of the early radiotherapeutics.

Download report here >>

Find out more about World Cancer Day here.

Enjoyed this article? Subscribe to Life Sciences Connect for weekly email updates >>

Share on LinkedInTweet about this on TwitterShare on Google+Share on FacebookShare on RedditDigg thisEmail this to someone


Leave a comment

You must be logged in to post a comment.